NURO

NeuroMetrix News

Company Name Stock Ticker Symbol Market Type
NeuroMetrix Inc NURO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.64 17:53:55
Open Price Low Price High Price Close Price Prev Close
1.65 1.602 1.6799 1.67 1.64
more quote information »

Recent News

Date Time Source Heading
11/08/202209:00GLOBENeuroMetrix to Introduce Quell® Fibromyalgia at the American..
11/03/202209:00GLOBENeuroMetrix Announces Strategic Launch of Quell Fibromyalgia
10/20/202207:16EDGARCurrent Report Filing (8-k)
10/20/202207:00GLOBENeuroMetrix Reports Q3 2022 Financial Results
10/12/202215:47GLOBENeuroMetrix, Inc. Announces Date for Third Quarter 2022..
9/01/202209:00GLOBENeuroMetrix Names Jonathan Breck Harmel as National Director..
8/31/202216:12EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/21/202216:57EDGARQuarterly Report (10-q)
7/21/202207:00GLOBENeuroMetrix Reports Q2 2022 Financial Results
7/14/202211:32GLOBENeuroMetrix, Inc. Announces Date for Second Quarter 2022..
7/06/202215:06EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202215:02EDGARInitial Statement of Beneficial Ownership (3)
6/28/202209:00GLOBENeuroMetrix Appoints Brad Fluegel to its Board of Directors
5/31/202215:43EDGARSpecialized Disclosure Report (sd)
5/26/202215:32EDGARStatement of Changes in Beneficial Ownership (4)
5/19/202209:00GLOBENeuroMetrix Reports that Quell® Wearable Neuromodulation..
4/26/202207:11EDGARCurrent Report Filing (8-k)
4/26/202207:00GLOBENeuroMetrix Reports Q1 2022 Financial Results
4/22/202210:51EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202209:00GLOBENeuroMetrix, Inc. Announces Date for First Quarter 2022..
3/24/202208:03EDGARProxy Statement (definitive) (def 14a)
2/24/202209:00GLOBENeuroMetrix Reports that Quell® Wearable Neuromodulator to..
1/27/202207:15EDGARCurrent Report Filing (8-k)
1/27/202207:06SEEKNeuroMetrix reports Q4 results
1/27/202207:00GLOBENeuroMetrix Reports Q4 and Full Year 2021 Financial Results
1/20/202212:10GLOBENeuroMetrix, Inc. Announces Date for Fourth Quarter and Full..
1/18/202211:06SEEKNeuroMetrix surges on FDA Breakthrough Designation for..
1/18/202209:00GLOBENeuroMetrix Receives FDA Breakthrough Device Designation for..
1/10/202209:00GLOBENeuroMetrix Names Strategic Growth Executive, Brandi..
1/05/202209:00GLOBENeuroMetrix to Present at H.C. Wainwright BioConnect..
12/10/202116:27EDGARCurrent Report Filing (8-k)
12/03/202116:07EDGARCurrent Report Filing (8-k)